Table 4.
Baseline, 1-Year, and 2-Year Post-HAART Initiation HIV Viral Load and CD4 Count Categorized by HBV Status
| Occult HBV (n = 72) |
Chronic HBV (n = 28) |
No HBV (n = 200) |
P Value | |
|---|---|---|---|---|
| CD4 at baseline, cells/uL | 169 (79–229) | 172 (93–238) | 159 (77–229) | .98 |
| CD4 at year 1, cells/uL | 339 (193–400) | 315 (244–391) | 323 (221–401) | .45 |
| CD4 at year 2, cells/uL | 386 (262–506) | 376 (320–480) | 372 (290–284) | .40 |
| HIV viral load, baseline, copies/mL | 144 000 (46 000–421 500) |
80 800 (30 625–505 750) |
131 000 (43 100–382 000) |
.70 |
| HIV viral load, year 1, copies/mL |
All <400 | All <400 | All <400 | — |
| HIV viral load, year 2, copies/mL |
All <400 | All <400 | All <400 | — |
Data represent median (interquartile range).
Abbreviations: HAART, highly active antiretroviral therapy; HBV, hepatitis B virus.